Develop robust biologics formulations faster with less material!
Click here to learn more about our products and services Learn More
Biologic drugs can be inherently prone to degradation and instability, making designing safe, stable, and effective formulations a challenge. To overcome these issues, developers perform screening and stability studies to identify suitable formulations; however, the number of formulations that can be screened for each project is often constrained by short timelines and a limited supply of material. The CM3 Biologics Formulation System is an end-to-end workflow for supporting high throughput buffer creation, buffer exchange, stressing, and analysis allowing for the rapid development of both protein formulations and vaccine formulations.
For more information, download the Biologics Formulation product sheet
Click here to view complete set of CM3 elements.